The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC). The new recommendations, which were published online May 16 in Physical Medicine & Rehabilitation, […]
Read More
Imani Ibrahim, a 33-year-old Chicago-based clinical social worker, became ill in January 2020. “I was very sick for a few days with flu-like symptoms. At that point, COVID-19 had not yet become a big outbreak, and I didn’t know what I had,” she said. Two months later, she went to […]
Read More
A new study finds no increased risk of rare neurological events after COVID-19 vaccination, but does find an increased risk of these events after SARS-CoV-2 infection. The European Medicines Agency (EMA) listed Guillain-Barré syndrome as a rare side effect of the Oxford-AstraZeneca and Pfizer-BioNTech COVID vaccines following reports that some […]
Read More
Watch for the big three red flags – cardiac (ischaemia, tachyarrhythmia, myocarditis and pericarditis), neurological (TIA and stroke) and respiratory (pulmonary embolism) in patients with long COVID, says the GP lead of one of the country’s first long COVID clinics. Dr Harsha Master, lead in COVID assessment and rehabilitation, Hertfordshire Community NHS […]
Read More
Johnson & Johnson’s Covid-19 vaccine may trigger a rare neurological condition in a small number of people who receive the vaccine, the Food and Drug Administration said Monday. Reports to a database operated jointly by the agency and the Centers for Disease Prevention and Control suggest there may be a […]
Read More
Concentrations of autoantibodies correlate with disease severity. Why do some people get so much sicker than others with acute COVID-19? And what causes the neurological symptoms — anosmia, fatigue, encephalopathy — seen in some patients? A team from Yale employed a new technology for finding autoantibodies to 2770 extracellular and […]
Read More
Concentrations of autoantibodies correlate with disease severity. Why do some people get so much sicker than others with acute COVID-19? And what causes the neurological symptoms — anosmia, fatigue, encephalopathy — seen in some patients? A team from Yale employed a new technology for finding autoantibodies to 2770 extracellular and […]
Read More
Summary Background Neurological and psychiatric sequelae of COVID-19 have been reported, but more data are needed to adequately assess the effects of COVID-19 on brain health. We aimed to provide robust estimates of incidence rates and relative risks of neurological and psychiatric diagnoses in patients in the 6 months following […]
Read More